Skip to main content
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in:

13-09-2023 | Colchicine | Correspondence

Familial Mediterranean fever during and post-COVID-19 pandemic

Author: Farhad Salehzadeh

Published in: Rheumatology International | Issue 10/2024

Login to get access

Excerpt

I read with great interest the article by Günendi Z et al., on clinical course and outcome of COVID-19 in FMF patients [1]. The authors found that the COVID-19 rate was as low as 7% in patients with FMF, moreover, the low rate of severe outcomes was detected (20% hospitalization, 3.4% complication and no death). Advanced age was found as a risk factor for hospitalization. Not only there was not a poor outcome of COVID-19 patients with FMF, but the course also seemed to be mild in this disease. …
Appendix
Available only for authorised users
Literature
1.
Günendi Z, Yurdakul FG, Bodur H, Cengiz AK, Uçar Ü, Çay HF, Şen N, Keskin Y, Gürer G, Melikoğlu MA, Altıntaş D, Deveci H, Baykul M, Nas K, Çevik R, Karahan AY, Toprak M, Ketenci S, Nayimoğlu M, Sezer I, Demir AN, Ecesoy H, Duruöz MT, Yurdakul OV, Sarıfakıoğlu AB, Ataman Ş (2021) The impact of COVID-19 on familial Mediterranean fever: a nationwide study. Rheumatol Int 41(8):1447–1455. https://​doi.​org/​10.​1007/​s00296-021-04892-6CrossRefPubMedPubMedCentral
2.
Xu W (2021) The role of colchicine in the treatment of COVID-19 Infection, an ancient medicine to combat current coronavirus pandemics? Ann Vasc Med Res 8(1):1127
3.
4.
Metadata
Title
Familial Mediterranean fever during and post-COVID-19 pandemic
Author
Farhad Salehzadeh
Publication date
13-09-2023
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05454-8

Other articles of this Issue 10/2024

Tocilizumab-induced psoriatic eruption : a case report and a case-based review

People with osteoarthritis have a higher component of neuropathic pain as compared to those with rheumatoid arthritis: A cross-sectional study

Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features

The relationship between MRI-detected hip abnormalities and hip pain in hip osteoarthritis: a systematic review

Chronobiological variables predict non-response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia: a cross-sectional study

High-intensity resistance training improves quality of life, muscle endurance and strength in patients with myositis: a randomised controlled trial

  • Open Access
  • Clinical Trials

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar
Image Credits